Literature DB >> 2692125

Are retroviruses involved in the pathogenesis of SLE? Evidence demonstrated by molecular analysis of nucleic acids from SLE patients' plasma.

F E Krapf1, M Herrmann, W Leitmann, J R Kalden.   

Abstract

High molecular weight DNA of up to 20 kbp and, additionally, an RNase-insensitive RNA of more than 60 b were isolated from plasmapheresis fluids taken from patients with active systemic lupus erythematosus (SLE). Similar nucleic acids could not be demonstrated in the plasma samples from patients with Waldenstroem's disease, rheumatoid arthritis, myasthenia gravis, and other diseases including active systemic disorders. The purified nucleic acids were analyzed in several ways; they proved to be immunogenic by inducing polyclonal and monoclonal antibodies to natural DNA as well as to synthetic polynucleotides (e.g. polyguanylic acid) after injection into experimental animals (rabbits or mice respectively). Biochemical and molecular cloning analysis of the DNA revealed features like high levels of CpG-dinucleotides, usually not observed in common human DNA. A possible exogenous origin was substantiated by comparative sequence studies of cloned plasma DNA, which showed homologies to human retroviruses, e.g. PL1 (85%/60 b) and the sequences of the gag and pol genes of human immunodeficiency virus type I (85%/157 b). Experiments applying isolated plasma nucleic acids in transfection experiments showed the induction of morphological changes in an EBV-immortalized B-cell line drawn from a healthy human donor, such as vacuolization and syncitia formation. Northern blot analysis demonstrated, exclusively in the transfected cell line, the expression of mRNA homologous to the cloned plasma DNA. Using this clone as a probe, homologous sequences could be demonstrated by Northern blot analysis in EBV-immortalized cell lines from SLE patients only and, by means of DNA amplification, in peripheral blood lymphocytes from SLE and AIDS patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692125     DOI: 10.1007/bf00271867

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  Appearance of circulating DNA during hemodialysis.

Authors:  C R Steinman; A Ackad
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Rapid sedimentation of Escherichia coli in the presence of polyethylene glycol at 1g.

Authors:  D L Eshenbaugh; D Sens; E James
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice.

Authors:  T Shirai; K Ohta; A Kohno; F Furukawa; H Yoshida; N Maruyama; S Hirose
Journal:  Arthritis Rheum       Date:  1986-02

5.  A comprehensive sequence analysis program for the IBM personal computer.

Authors:  C Queen; L J Korn
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA.

Authors:  K C Kuo; R A McCune; C W Gehrke; R Midgett; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1980-10-24       Impact factor: 16.971

7.  Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus.

Authors:  S Chitrabamrung; R L Rubin; E M Tan
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

8.  Evidence in patients with systemic lupus erythematosus of the presence of antibodies against RNA-dependent DNA polymerase of baboon endogenous virus.

Authors:  T Okamoto; T Tamura; T Takano
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

9.  Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders.

Authors:  M Rucheton; H Graafland; H Fanton; L Ursule; P Ferrier; C J Larsen
Journal:  Virology       Date:  1985-07-30       Impact factor: 3.616

10.  Serological and virological evidence of human T-lymphotropic virus in systemic lupus erythematosus.

Authors:  R G Olsen; M J Tarr; L E Mathes; R Whisler; D Du Plessis; E J Schulz; J R Blakeslee
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

View more
  5 in total

1.  High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus.

Authors:  Victoria Carter; John LaCava; Martin S Taylor; Shu Ying Liang; Cecilia Mustelin; Kennedy C Ukadike; Anders Bengtsson; Christian Lood; Tomas Mustelin
Journal:  Arthritis Rheumatol       Date:  2020-01       Impact factor: 10.995

Review 2.  Pathogenesis of SLE: immunopathology in man.

Authors:  J R Kalden; T H Winkler; M Herrmann; F Krapf
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.

Authors:  Clio P Mavragani; Irina Sagalovskiy; Qiu Guo; Adrianos Nezos; Efstathia K Kapsogeorgou; Pin Lu; Jun Liang Zhou; Kyriakos A Kirou; Surya V Seshan; Haralampos M Moutsopoulos; Mary K Crow
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

4.  Developing a Continuous Quality Improvement Assessment Using a Patient-Centered Approach in Optimizing Systemic Lupus Erythematosus Disease Control.

Authors:  Katelyn Mariko Updyke; Brittany Urso; Shazia Beg; James Solomon
Journal:  Cureus       Date:  2017-10-09

5.  Increased Transfection of the Easily Oxidizable GC-Rich DNA Fragments into the MCF7 Breast Cancer Cell.

Authors:  Svetlana V Kostyuk; Nadezhda N Mordkovich; Natalya A Okorokova; Vladimir P Veiko; Elena M Malinovskaya; Elizaveta S Ershova; Marina S Konkova; Ekaterina A Savinova; Maria A Borzikova; Tatiana A Muzaffarova; Lev N Porokhovnik; Nataly N Veiko; Serguey I Kutsev
Journal:  Oxid Med Cell Longev       Date:  2019-02-05       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.